Discussions
Nouveau POST 00910E : VACCINE WASTAGE
POST 00910E : VACCINE WASTAGE
Follow-up on Posts 00889E, 00894E, 00899E and 00906E
11 April 2006
This posting contains a contribution from Sridharan Rangachari
(mailto:[email protected]) from India.
I fully agree with Anthony's view:
"The quantity of Hepatitis B vaccine "wasted" by Niger...
Nouveau Post 00906e : Wastage Rates
POST 00906E : WASTAGE RATES
Follow-up on Posts 00889E, 00894E and 00899E
2 April 2006
This posting is a continuation of the discussion started by questions on a
new WHO site by Femi Odegbami. In this posting Anthony Battersby
(mailto:[email protected]) contributes further with comments on ...
POST 00877E : COMMENTS ON HEPB ARTICLE
Follow-up on Post 00875E
12 January 2006
Anil Varshney (mailto:[email protected]) from India shares some
comments on the article by Hipgrave et al. Comments on articles are seldom
submitted to the forum but are quite welcome.
Dear All,
The findi...
POST 00875E : ARTICLES OF INTEREST 8 January 2006
This posting contains links to two quite interesting articles, both hosted
on our site to facilitate access. The first "Cervical Cancer, Human
Papillomavirus and Vaccination" by Catherine M. Lowndes and O. Noel Gill,
is an editorial reproduc...
POST 00869E : COMBINATION VACCINES, LYOPHILIZED VACCINES, DILUENTS AND VVMS
Follow-up on Posts 00847E, 00852E, 00855E, 00858E, 00860E and 00864E
26 December 2005
Michel Zaffran (mailto:[email protected]) from WHO draws some conclusions
from this discussion started by his message of 26 October....
POST 00826E : NEEDLE-REMOVER STUDY
Follow-up on Post 00818E
23 August 2005
This posting contains two contributions. The first is from Mary Catlin
(mailto:[email protected]) from The United States, followed by that of
Ville Lehto (mailto:[email protected]) from Finland.
The ...
Nouveau Post 00799e : Eradication
POST 00799E : ERADICATION 12 June 2005
It seems that I am in another string of mistakes from my part. My
apologies! The links below are corrected, I had obviously forgotten the
extension to our site.
Robert Davis (mailto:[log in to unmask]) from UNICEF/ESARO had wanted to
discuss eradicati...
Nouveau POST 00799E : ERADICATION
POST 00799E : ERADICATION 12 June 2005
It seems that I am in another string of mistakes from my part. My
apologies! The links below are corrected, I had obviously forgotten the
extension to our site.
Robert Davis (mailto:[email protected]) from UNICEF/ESARO had wanted to
discuss eradicatio...
POST 00773E : INTERVAL INJURY-PROTECTION
Follow-up on Post 00764E
9 April 2005
In response to Vladimir Petrovic's request, this posting contains two
contributions. The first is from (mailto:[email protected]) from the
United States and the second from David Hipgrave
(mailto:dhipgrave@unice...
POST 00742E : HEPb VACCINATION : REGIONAL STRATEGIES
Follow-up to Post 00734E
14 January 2005
NOTE:
This message was sent on Friday 14th of January. For a mysterious
reason, it didn't reach LISTSERV thus went unsent to members. It didn't go
through on a second attempt. Let's see if it work...
POST 00742E : HEPb VACCINATION : REGIONAL STRATEGIES
Follow-up to Post 00734E
14 January 2005
NOTE:
This message was sent on Friday 14th of January. For a mysterious
reason, it didn't reach LISTSERV thus went unsent to members. It didn't go
through on a second attempt. Let's see if it work...
POST 00734E : HEPb VACCINATION : REGIONAL STRATEGIES
28 December 2004
This contribution comes from Ricardo F. Morales Moreno
(mailto:[email protected]) from Peru.
NOTE :
Originally in Spanish, this contribution was received a long time
ago. Translation from Spanish to English, then to F...
POST 00706E : ACCIDENTAL NEEDLESTICK
Follow-up on Post 00701E
15 August 2004
Two replies were received following Vladimir's Petrovic's posting (00701E).
The first is from Steve Wiersma (mailto:[email protected]) from WHO who
discusses the issue. The second came from Tina Norgard
(mailto:tnorg...
POST 00701E : ACCIDENTAL NEEDLESTICK 28 July 2004
Vladimir Petrovic (mailto:[email protected]) from Serbia-Montenegro, asks a
question that goes far beyond the scope of secondary prevention in public
health. I will let specialists respond to the question of immediate
Hepatitis B risks in the ci...
POST 00684E : APPROACHES TO ELIMINATING FREEZING : A STUDY REPORT 9 June 2004
Carib Nelson (mailto:[email protected]) informs us of a study done at PATH.
The full document "Approaches to Eliminating Freezing in Vaccine
Carriers—Testing Report Summary—" can be downloaded from
http://www.technet...
POST 00682E : HepB VACCINE DOSES INTERVAL
Follow-up on Post 00674E
3 June 2004
Three colleagues contributed answers to Vladimir Petrovic's question on
HepB doses interval. First Ann Kempe (mailto:[email protected]) from
Australia, followed by Mary Catlin (mailto:[email protected]) ...
POST 00674E : HepB VACCINE DOSES INTERVAL 16 May 2004
Vladimir Petrovic (mailto:[email protected]) from Serbia & Montenegro has a
question on dose intervals for HepB vaccine. As replies could interest
other members, please copy to TechNet21.
Dear colleagues,
I would like to hear your opin...
Nouveau POST 00643E : COMBATING RUMOURS
POST 00643E : COMBATING RUMOURS
Follow-up on Post 00619E
27 February 2004
A massive polio immunization effort has just been completed where 63
million children were vaccinated in a synchronized manner across 10 West
African countries. This was highly critical for reaching the goal of
eradica...
POST 00579E : VACCINE FREEZING, FREEZEWATCH AND SHAKE TEST
Follow-up on POSTS 00571E, 00574E and 00575E
4 July 2003
This posting contains 4 contributions and exceptionally will cover more
than one specific topic as they are all related to vaccine freezing. The
first translated from French is ...
Nouveau POST 00575E : VACCINE FREEZING
POST 00575E : VACCINE FREEZING
Follow-up on POSTS 00571E and 00574E
28 June 2003
This posting contains three contributions. The first is from Pham Ngoc Len
(mailto:[log in to unmask]) from UNICEF. He brings up an issue related to
vaccine freezing, the shake test.
The second contribution is f...
Il n'existe aucune discussion disponible ici